Please assess the completion status of the following clinical trial:

Trial Title: FLOTRAC/VIGILEO in Acute Circulatory Failure

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CROSSOVER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Systolic arterial pressure \< 90 mmHg or Mean arterial pressure \< 60 mmHg~* Heart rate \> 100 bpm~* Norepinephrine infusion~* Urine output \< 0.5 ml/kg/h during at least two consecutive hours~* skin mottling~* Capillary refill time \> 3 sec~Exclusion Criteria:~* Acute cor pulmonale~* Ongoing renal replacement therapy~* Lack of echogenicity during transthoracic echocardiography

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).